Aleksandar Pavlović
Aleksandar Pavlović has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Nebojsa Videnovic
Faculty of Medicine, University of Pristina, 38220 Kosovska Mitrovica, Serbia
3 shared publications - Bojan Joksimović
Faculty of Medicine Foča, University of East Sarajevo, 73300 Foča, Bosnia and Herzegovina
2 shared publications - Jelena Filimonovic
Department of Epidemiology, University of Pristina Temporarily Settled in Kosovska Mitrovica, 38220 Kosovska Mitrovica, Serbia
2 shared publications - Ksenija Bojovic
Faculty of Medicine Foča, University of East Sarajevo, 73300 Foča, Bosnia and Herzegovina
2 shared publications - Marija Milic
Department of Epidemiology, Faculty of Medicine, University of Pristina temporarily settled in Kosovska Mitrovica, Kosovska Mitrovica, Kosovo, Serbia
2 shared publications - Milena Anđelković
Clinical Hospital Center Kosovska Mitrovica, 38220 Kosovska Mitrovica, Serbia
2 shared publications
Latest Publications
- Open Access
Characteristics, Associated Factors, and Outcomes of Cardiac Arrest in Critically Ill COVID-19 Patients in the Intensive Care Unit: A Single-Center Retrospective Study
Background and Objectives: In-hospital cardiac arrest (IHCA) in critically ill patients with COVID-19 is among the most severe clinical outcomes, associated with high mortality and a significant risk to healthcare workers during cardiopulmonary resuscitation (CPR). The aim of this study was to evaluate the incidence, characteristics, associated factors, and outcomes of IHCA among COVID-19 patients treated in the intensive care unit (ICU), with particular emphasis on resuscitation outcomes and survival. Materials and Methods: A retrospective cohort study was conducted including critically ill patients with confirmed SARS-CoV-2 infection treated in the ICU of the Clinical-Hospital Center (KBC) in Kosovska Mitrovica between March 2020 and December 2022. Patients were categorized into two groups: (1) CA group—patients who experienced CA in the ICU, and (2) non-CA group—patients who did not experience CA during ICU treatment. Results: A total of 222 patients were analyzed, of whom 114 (51.4%) experienced IHCA. Patients with IHCA were significantly older, more frequently obese, and had a higher burden of comorbidities. They also exhibited more pronounced hematological and inflammatory abnormalities, including lower erythrocyte and hemoglobin levels, thrombocytopenia, and elevated leukocyte counts, fibrinogen, C-reactive protein, and procalcitonin levels. In addition, higher lactate and D-dimer concentrations were observed, along with a more frequent occurrence of hyperkalemia and hypernatremia. The predominant cause of IHCA was respiratory failure, most commonly associated with severe hypoxemia (59.6%), while non-shockable initial rhythms (asystole and pulseless electrical activity (PEA)) were most common (76.3%). Among patients with IHCA, return of spontaneous circulation (ROSC) was achieved in 11 patients (9.6%), and 3 patients (2.6%) survived to hospital discharge. Conclusions: Despite rapid response and CPR in the ICU setting, outcomes remained poor. More favorable outcomes were observed mainly in cases with potentially reversible etiologies (such as myocardial infarction and pulmonary embolism (PE)), in contrast to hypoxia-mediated CA.
Open AccessCharacteristics, Associated Factors, and Outcomes of Cardiac Arrest in Critically Ill COVID-19 Patients in the Intensive Care Unit: A Single-Center Retrospective Study
Background and Objectives: In-hospital cardiac arrest (IHCA) in critically ill patients with COVID-19 is among the most severe clinical outcomes, associated with high mortality and a significant risk to healthcare workers during cardiopulmonary resuscitation (CPR). The aim of this study was to evaluate the incidence, characteristics, associated factors, and outcomes of IHCA among COVID-19 patients treated in the intensive care unit (ICU), with particular emphasis on resuscitation outcomes and survival. Materials and Methods: A retrospective cohort study was conducted including critically ill patients with confirmed SARS-CoV-2 infection treated in the ICU of the Clinical-Hospital Center (KBC) in Kosovska Mitrovica between March 2020 and December 2022. Patients were categorized into two groups: (1) CA group—patients who experienced CA in the ICU, and (2) non-CA group—patients who did not experience CA during ICU treatment. Results: A total of 222 patients were analyzed, of whom 114 (51.4%) experienced IHCA. Patients with IHCA were significantly older, more frequently obese, and had a higher burden of comorbidities. They also exhibited more pronounced hematological and inflammatory abnormalities, including lower erythrocyte and hemoglobin levels, thrombocytopenia, and elevated leukocyte counts, fibrinogen, C-reactive protein, and procalcitonin levels. In addition, higher lactate and D-dimer concentrations were observed, along with a more frequent occurrence of hyperkalemia and hypernatremia. The predominant cause of IHCA was respiratory failure, most commonly associated with severe hypoxemia (59.6%), while non-shockable initial rhythms (asystole and pulseless electrical activity (PEA)) were most common (76.3%). Among patients with IHCA, return of spontaneous circulation (ROSC) was achieved in 11 patients (9.6%), and 3 patients (2.6%) survived to hospital discharge. Conclusions: Despite rapid response and CPR in the ICU setting, outcomes remained poor. More favorable outcomes were observed mainly in cases with potentially reversible etiologies (such as myocardial infarction and pulmonary embolism (PE)), in contrast to hypoxia-mediated CA.
- Open Access
Association of GSTM1 and GSTT1 Null Genotypes with Disease Severity and Serum Cytokine Levels in Hospitalized COVID-19 Patients
Background: The clinical course of COVID-19 is highly variable, ranging from asymptomatic infection to critical illness with hyperinflammation and multiorgan failure. Oxidative stress plays a central role in COVID-19 pathogenesis, and genetic polymorphisms in glutathione S-transferase (GST) enzymes, particularly GSTM1 and GSTT1 null genotypes, may impair antioxidant defense and exacerbate inflammatory responses. This study aimed to investigate the association of GSTM1 and GSTT1 null genotypes with both disease severity and serum cytokine levels in hospitalized COVID-19 patients. Methods: This cross-sectional study enrolled 137 COVID-19 patients hospitalized during the second pandemic wave (July–September 2020). Patients were stratified into mild (n = 67) and severe (n = 70) groups based on clinical criteria. GSTM1 and GSTT1 polymorphisms were determined by multiplex polymerase chain reaction. Serum levels of 13 cytokines were measured using flow cytometry. Logistic regression analyzed genotype associations with disease severity, and multivariate linear regression assessed relationships between null genotypes and pro-inflammatory cytokine levels (IL-6, TNF-α, IL-17A, IFN-γ), adjusted for age, sex, hypertension, and diabetes. Results: The GSTT1 null genotype was significantly associated with severe COVID-19 (adjusted OR = 2.56, 95% CI: 1.08–6.07, p = 0.032). Severe patients exhibited significantly elevated levels of IL-6 (75.6% increase, p = 0.008), TNF-α (69.4% increase, p = 0.005), IL-17A (54.4% increase, p = 0.016), and IFN-γ (10.1% increase, p = 0.021). Both GSTM1 and GSTT1 null genotypes were associated with higher levels of these cytokines, with stronger effects observed for GSTT1 null. In multivariate analysis, GSTT1 null independently predicted elevated IL-6 (β = 52.6, p = 0.003), TNF-α (β = 13.8, p = 0.002), IL-17A (β = 2.4, p = 0.001), and IFN-γ (β = 56.4, p = 0.012). The combined both null genotype showed the strongest associations but was limited by small sample size (n = 10) and should be interpreted with caution. Conclusions: The GSTT1 null genotype is associated with severe COVID-19 and appears to be associated with heightened pro-inflammatory cytokine responses, particularly IL-6, TNF-α, IL-17A, and IFN-γ. These findings suggest a potential role for genetic impairment of antioxidant defense may contribute to hyperinflammation in COVID-19 hyperinflammation, although validation in larger cohorts is needed.
Open AccessAssociation of GSTM1 and GSTT1 Null Genotypes with Disease Severity and Serum Cytokine Levels in Hospitalized COVID-19 Patients
Background: The clinical course of COVID-19 is highly variable, ranging from asymptomatic infection to critical illness with hyperinflammation and multiorgan failure. Oxidative stress plays a central role in COVID-19 pathogenesis, and genetic polymorphisms in glutathione S-transferase (GST) enzymes, particularly GSTM1 and GSTT1 null genotypes, may impair antioxidant defense and exacerbate inflammatory responses. This study aimed to investigate the association of GSTM1 and GSTT1 null genotypes with both disease severity and serum cytokine levels in hospitalized COVID-19 patients. Methods: This cross-sectional study enrolled 137 COVID-19 patients hospitalized during the second pandemic wave (July–September 2020). Patients were stratified into mild (n = 67) and severe (n = 70) groups based on clinical criteria. GSTM1 and GSTT1 polymorphisms were determined by multiplex polymerase chain reaction. Serum levels of 13 cytokines were measured using flow cytometry. Logistic regression analyzed genotype associations with disease severity, and multivariate linear regression assessed relationships between null genotypes and pro-inflammatory cytokine levels (IL-6, TNF-α, IL-17A, IFN-γ), adjusted for age, sex, hypertension, and diabetes. Results: The GSTT1 null genotype was significantly associated with severe COVID-19 (adjusted OR = 2.56, 95% CI: 1.08–6.07, p = 0.032). Severe patients exhibited significantly elevated levels of IL-6 (75.6% increase, p = 0.008), TNF-α (69.4% increase, p = 0.005), IL-17A (54.4% increase, p = 0.016), and IFN-γ (10.1% increase, p = 0.021). Both GSTM1 and GSTT1 null genotypes were associated with higher levels of these cytokines, with stronger effects observed for GSTT1 null. In multivariate analysis, GSTT1 null independently predicted elevated IL-6 (β = 52.6, p = 0.003), TNF-α (β = 13.8, p = 0.002), IL-17A (β = 2.4, p = 0.001), and IFN-γ (β = 56.4, p = 0.012). The combined both null genotype showed the strongest associations but was limited by small sample size (n = 10) and should be interpreted with caution. Conclusions: The GSTT1 null genotype is associated with severe COVID-19 and appears to be associated with heightened pro-inflammatory cytokine responses, particularly IL-6, TNF-α, IL-17A, and IFN-γ. These findings suggest a potential role for genetic impairment of antioxidant defense may contribute to hyperinflammation in COVID-19 hyperinflammation, although validation in larger cohorts is needed.
- Open Access
- 8 December 2025
- Published by MDPI AG in Preprints.org
Predictive Factors of Early and One-Year Mortality in Patients with Acute Pancreatitis
Background/Objectives: Acute Pancreatitis (AP) is an unpredictable inflammatory disease associated with high morbidity and significant mortality, particularly in severe forms. Early death is primarily linked to Systemic Inflammatory Response Syndrome (SIRS) and Multi-Organ Failure (MOF). The objective of this study was to identify objective clinical and laboratory predictors of early and one-year mortality in AP patients and to evaluate the prognostic accuracy of commonly used severity scoring systems. Methods: This prospective, observational study enrolled 50 adult patients admitted to the Intensive Care Unit (ICU) at the University Hospital Center Bežaniska Kosa. Patients with chronic pancreatitis, trauma-induced AP, or late presentation were excluded. Severity scores (APACHE II, BISAP, Ranson, Pancreas) and biomarkers (C-reactive protein, Procalcitonin) were collected at admission (0h) and dynamically at 48-72h and day 7. Endpoints were early (in-hospital) and one-year mortality. Results: Overall mortality was 16% (n=8). Mortality was significantly associated with sepsis/septic shock (p<0.001), severe AP ($p=0.001$), prolonged mechanical ventilation, and ICU stay. At admission, APACHE II (AUROC 0.813) and BISAP (AUROC 0.807) showed good accuracy. Reassessment at 48 hours markedly improved prediction: APACHE II achieved excellent value (AUROC 0.917), and the Ranson score became a strong predictor (p<0.001). Procalcitonin (PCT) was identified as a significant and superior predictor of mortality from 48 hours onwards (p<0.001), outperforming CRP. One-year survival was significantly shorter among patients with sepsis, septic shock, severe AP, and prolonged ICU stay. Conclusions: Dynamic assessment using clinical scoring systems, particularly APACHE II and BISAP within the first 48 hours, provides reliable mortality prediction in acute pancreatitis. The presence of sepsis, severe disease, and the need for prolonged organ support are key mortality determinants. Serial PCT monitoring offers sensitive, incremental value for risk stratification and guiding intensive care decisions in both short- and long-term outcomes.
- 8 December 2025
- Published by MDPI AG in Preprints.org
Open AccessPredictive Factors of Early and One-Year Mortality in Patients with Acute Pancreatitis
Background/Objectives: Acute Pancreatitis (AP) is an unpredictable inflammatory disease associated with high morbidity and significant mortality, particularly in severe forms. Early death is primarily linked to Systemic Inflammatory Response Syndrome (SIRS) and Multi-Organ Failure (MOF). The objective of this study was to identify objective clinical and laboratory predictors of early and one-year mortality in AP patients and to evaluate the prognostic accuracy of commonly used severity scoring systems. Methods: This prospective, observational study enrolled 50 adult patients admitted to the Intensive Care Unit (ICU) at the University Hospital Center Bežaniska Kosa. Patients with chronic pancreatitis, trauma-induced AP, or late presentation were excluded. Severity scores (APACHE II, BISAP, Ranson, Pancreas) and biomarkers (C-reactive protein, Procalcitonin) were collected at admission (0h) and dynamically at 48-72h and day 7. Endpoints were early (in-hospital) and one-year mortality. Results: Overall mortality was 16% (n=8). Mortality was significantly associated with sepsis/septic shock (p<0.001), severe AP ($p=0.001$), prolonged mechanical ventilation, and ICU stay. At admission, APACHE II (AUROC 0.813) and BISAP (AUROC 0.807) showed good accuracy. Reassessment at 48 hours markedly improved prediction: APACHE II achieved excellent value (AUROC 0.917), and the Ranson score became a strong predictor (p<0.001). Procalcitonin (PCT) was identified as a significant and superior predictor of mortality from 48 hours onwards (p<0.001), outperforming CRP. One-year survival was significantly shorter among patients with sepsis, septic shock, severe AP, and prolonged ICU stay. Conclusions: Dynamic assessment using clinical scoring systems, particularly APACHE II and BISAP within the first 48 hours, provides reliable mortality prediction in acute pancreatitis. The presence of sepsis, severe disease, and the need for prolonged organ support are key mortality determinants. Serial PCT monitoring offers sensitive, incremental value for risk stratification and guiding intensive care decisions in both short- and long-term outcomes.
- Open Access
- 10 June 2024
- Published by MDPI AG in Biomedicines
- Vol. 12 (6) , 1281
The Impact of Cytokines on Coagulation Profile in COVID-19 Patients: Controlled for Socio-Demographic, Clinical, and Laboratory Parameters
Background: Severe coagulation abnormalities are common in patients with COVID-19 infection. We aimed to investigate the relationship between pro-inflammatory cytokines and coagulation parameters concerning socio-demographic, clinical, and laboratory characteristics. Methods: Our study included patients hospitalized during the second wave of COVID-19 in the Republic of Serbia. We collected socio-demographic, clinical, and blood-sample data for all patients. Cytokine levels were measured using flow cytometry. Results: We analyzed data from 113 COVID-19 patients with an average age of 58.15 years, of whom 79 (69.9%) were male. Longer duration of COVID-19 symptoms before hospitalization (B = 69.672; p = 0.002) and use of meropenem (B = 1237.220; p = 0.014) were predictive of higher D-dimer values. Among cytokines, higher IL-5 values significantly predicted higher INR values (B = 0.152; p = 0.040) and longer prothrombin times (B = 0.412; p = 0.043), and higher IL-6 (B = 0.137; p = 0.003) predicted longer prothrombin times. Lower IL-17F concentrations at admission (B = 0.024; p = 0.050) were predictive of higher INR values, and lower IFN-γ values (B = −0.306; p = 0.017) were predictive of higher aPTT values. Conclusions: Our findings indicate a significant correlation between pro-inflammatory cytokines and coagulation-related parameters. Factors such as the patient’s level of education, gender, oxygen-therapy use, symptom duration before hospitalization, meropenem use, and serum concentrations of IL-5, IL-6, IL-17F, and IFN-γ were associated with worse coagulation-related parameters.
- 10 June 2024
- Published by MDPI AG in Biomedicines
- Vol. 12 (6) , 1281
Open AccessThe Impact of Cytokines on Coagulation Profile in COVID-19 Patients: Controlled for Socio-Demographic, Clinical, and Laboratory Parameters
Background: Severe coagulation abnormalities are common in patients with COVID-19 infection. We aimed to investigate the relationship between pro-inflammatory cytokines and coagulation parameters concerning socio-demographic, clinical, and laboratory characteristics. Methods: Our study included patients hospitalized during the second wave of COVID-19 in the Republic of Serbia. We collected socio-demographic, clinical, and blood-sample data for all patients. Cytokine levels were measured using flow cytometry. Results: We analyzed data from 113 COVID-19 patients with an average age of 58.15 years, of whom 79 (69.9%) were male. Longer duration of COVID-19 symptoms before hospitalization (B = 69.672; p = 0.002) and use of meropenem (B = 1237.220; p = 0.014) were predictive of higher D-dimer values. Among cytokines, higher IL-5 values significantly predicted higher INR values (B = 0.152; p = 0.040) and longer prothrombin times (B = 0.412; p = 0.043), and higher IL-6 (B = 0.137; p = 0.003) predicted longer prothrombin times. Lower IL-17F concentrations at admission (B = 0.024; p = 0.050) were predictive of higher INR values, and lower IFN-γ values (B = −0.306; p = 0.017) were predictive of higher aPTT values. Conclusions: Our findings indicate a significant correlation between pro-inflammatory cytokines and coagulation-related parameters. Factors such as the patient’s level of education, gender, oxygen-therapy use, symptom duration before hospitalization, meropenem use, and serum concentrations of IL-5, IL-6, IL-17F, and IFN-γ were associated with worse coagulation-related parameters.
- Open Access
- 1 January 2023
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Galenika Medical Journal
- Vol. 2 (8) , 44-52
In-flight medical emergencies: "Is there a doctor on board?"
Almost four billion passengers travel aboard commercial airliners every year. Last year In-flight medical emergencies (IMEs) were relatively common and occurred in a complex environment with limited medical resources. More recent data shows that IMEs occur in one passenger for every 604 flights or 24-130 IMEs for every one million passengers, more often in people over 70 years old. Due to the drop in barometric pressure, there are specific conditions in the aircraft passenger cabin that can affect the occurrence of IMEs. Most importantly it is hypobaric hypoxia, which can lead to the development of hypoxia-related symptoms in chronic patients with respiratory, cardiovascular, and hematological diseases. With reduced barometric pressure gases in body cavities and medical equipment can expand by 30%, this can lead to IMEs in recently operated patients (wound dehiscence, bleeding), middle ear and sinus diseases, subocclusions, and lung problems (pulmonary bulla). Other factors that contribute to the occurrence of IMEs are limited movement (deep vein thrombosis), dry and cold air (dehydration), jet lag, turbulence, and psychological stress. IMEs most commonly involve syncope or near-syncope (32.7%), gastrointestinal (14.8%), respiratory (10.1%), and cardiovascular (7.0%) symptoms. Because of ethical, and in some countries also legal responsibilities, doctor-passengers are a great help in the treatment of IMEs. Emergency landing of the aircraft when an IME occurs happens in an estimated 4.4% of cases. Knowing the influence of the specific ambient conditions in the plane on physiological processes in the body is of great importance for determining the absolute and relative contraindications for flying by plane. Doctor-passengers have an important role in the treatment of IMEs. This work aims to introduce us to the specific ambient conditions in the aircraft cabin and their influence on the physiology of the human body, the most common IMEs that occur under the influence of those conditions, the role of the doctorpassenger as well as the absolute and relative contraindications for flying by plane.
- 1 January 2023
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Galenika Medical Journal
- Vol. 2 (8) , 44-52
Open AccessIn-flight medical emergencies: "Is there a doctor on board?"
Almost four billion passengers travel aboard commercial airliners every year. Last year In-flight medical emergencies (IMEs) were relatively common and occurred in a complex environment with limited medical resources. More recent data shows that IMEs occur in one passenger for every 604 flights or 24-130 IMEs for every one million passengers, more often in people over 70 years old. Due to the drop in barometric pressure, there are specific conditions in the aircraft passenger cabin that can affect the occurrence of IMEs. Most importantly it is hypobaric hypoxia, which can lead to the development of hypoxia-related symptoms in chronic patients with respiratory, cardiovascular, and hematological diseases. With reduced barometric pressure gases in body cavities and medical equipment can expand by 30%, this can lead to IMEs in recently operated patients (wound dehiscence, bleeding), middle ear and sinus diseases, subocclusions, and lung problems (pulmonary bulla). Other factors that contribute to the occurrence of IMEs are limited movement (deep vein thrombosis), dry and cold air (dehydration), jet lag, turbulence, and psychological stress. IMEs most commonly involve syncope or near-syncope (32.7%), gastrointestinal (14.8%), respiratory (10.1%), and cardiovascular (7.0%) symptoms. Because of ethical, and in some countries also legal responsibilities, doctor-passengers are a great help in the treatment of IMEs. Emergency landing of the aircraft when an IME occurs happens in an estimated 4.4% of cases. Knowing the influence of the specific ambient conditions in the plane on physiological processes in the body is of great importance for determining the absolute and relative contraindications for flying by plane. Doctor-passengers have an important role in the treatment of IMEs. This work aims to introduce us to the specific ambient conditions in the aircraft cabin and their influence on the physiology of the human body, the most common IMEs that occur under the influence of those conditions, the role of the doctorpassenger as well as the absolute and relative contraindications for flying by plane.
- Open Access
- 1 January 2018
- Published by National Library of Serbia in Srpski arhiv za celokupno lekarstvo
- Vol. 146 (5-6) , 338-344
The application of simulation in medical education - our experience “from improvisation to simulation”
While the use of simulation in medical education has a long history, it has seen its greatest strides in the past 15-odd years. It may be defined as imitation, artificial while at the same time faithful, of various clinical situations through well-crafted medical ?scenarios? where, instead of actual people, we use standardized patients: plant, animal, or synthetic models, computerized interactive manikins ? simulators, with audiovisuals, as well as medical equipment used in everyday clinical practice. The fundamental goal of using simulation in medical education is an optimal balance between professional education on the one hand and complete safety and protection of patients on the other. Depending on the available finances and the level of advancement of the healthcare and education systems, medical simulation can take various forms ? from simple improvisation to the creation of a high-fidelity simulation in centers for medical simulation. Our example shows that, even with modest financial means, enthusiasm, creativity, and good ideas make it possible to establish a center for medical simulation. A separate section of the paper is devoted to the staging of a simulation scenario based on the authors? experiences.
- 1 January 2018
- Published by National Library of Serbia in Srpski arhiv za celokupno lekarstvo
- Vol. 146 (5-6) , 338-344
Open AccessThe application of simulation in medical education - our experience “from improvisation to simulation”
While the use of simulation in medical education has a long history, it has seen its greatest strides in the past 15-odd years. It may be defined as imitation, artificial while at the same time faithful, of various clinical situations through well-crafted medical ?scenarios? where, instead of actual people, we use standardized patients: plant, animal, or synthetic models, computerized interactive manikins ? simulators, with audiovisuals, as well as medical equipment used in everyday clinical practice. The fundamental goal of using simulation in medical education is an optimal balance between professional education on the one hand and complete safety and protection of patients on the other. Depending on the available finances and the level of advancement of the healthcare and education systems, medical simulation can take various forms ? from simple improvisation to the creation of a high-fidelity simulation in centers for medical simulation. Our example shows that, even with modest financial means, enthusiasm, creativity, and good ideas make it possible to establish a center for medical simulation. A separate section of the paper is devoted to the staging of a simulation scenario based on the authors? experiences.
- Open Access
- 1 January 2018
- Published by National Library of Serbia in Srpski arhiv za celokupno lekarstvo
- Vol. 146 (1-2) , 90-94
Is there a doctor on the plane? The distinctive conditions of cardiopulmonary resuscitation on commercial flights
Even today, when over 3.5 billion passengers travel on commercial flights each year, there is confusion about the duties and role of doctors and other licensed medical professionals volunteering to provide assistance to a passenger whose life is in jeopardy, especially when it comes to measures of cardiopulmonary resuscitation in the distinctive conditions of an airborne commercial aircraft. There are still no international, standardized guidelines, rulebooks, or instructions applying to all airlines when it comes to training and organizing the cabin crew, equipping emergency medical kits and covering the role of medical professionals volunteering their services in medical emergency situations. The aim of this work was to attempt to solve a common quandary among medical professionals when it comes to airplane travel. Based on the available literature, national and regional guidelines and rulebooks of airlines, in accordance with the ethical and legal principles binding medical professionals, we have attempted to answer the major questions related to cardiopulmonary resuscitation on commercial flights. All aspects are covered ? from a doctor volunteering to provide emergency medical care, through the marshalling of the cabin attendants, the availability of equipment, interaction with the flight captain and the captain?s decision whether to perform an emergency landing, to the possibility of obtaining additional information from medical call centers on the ground and calling medical crews to the nearest airport.
- 1 January 2018
- Published by National Library of Serbia in Srpski arhiv za celokupno lekarstvo
- Vol. 146 (1-2) , 90-94
Open AccessIs there a doctor on the plane? The distinctive conditions of cardiopulmonary resuscitation on commercial flights
Even today, when over 3.5 billion passengers travel on commercial flights each year, there is confusion about the duties and role of doctors and other licensed medical professionals volunteering to provide assistance to a passenger whose life is in jeopardy, especially when it comes to measures of cardiopulmonary resuscitation in the distinctive conditions of an airborne commercial aircraft. There are still no international, standardized guidelines, rulebooks, or instructions applying to all airlines when it comes to training and organizing the cabin crew, equipping emergency medical kits and covering the role of medical professionals volunteering their services in medical emergency situations. The aim of this work was to attempt to solve a common quandary among medical professionals when it comes to airplane travel. Based on the available literature, national and regional guidelines and rulebooks of airlines, in accordance with the ethical and legal principles binding medical professionals, we have attempted to answer the major questions related to cardiopulmonary resuscitation on commercial flights. All aspects are covered ? from a doctor volunteering to provide emergency medical care, through the marshalling of the cabin attendants, the availability of equipment, interaction with the flight captain and the captain?s decision whether to perform an emergency landing, to the possibility of obtaining additional information from medical call centers on the ground and calling medical crews to the nearest airport.